IL209842A0
(en )
2011-02-28
Compounds for the treatment of metabolic disorders
TWI345979B
(en )
2011-08-01
Topical pharmaceutical compositions for the treatment of dermatitis
ZA200504558B
(en )
2010-04-28
Compounds for the treatment of metabolic disorders
HK1078858A1
(en )
2006-03-24
Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
IL175529A0
(en )
2006-09-05
Methods and compositions for the treatment of metabolic disorders
AU2003286567A1
(en )
2004-05-13
Methods for the treatment of skin disorders
ZA200401004B
(en )
2006-03-29
Combination for the treatment of inflammatory disorders
AU2003228819A1
(en )
2003-11-17
Combinations for the treatment of inflammatory skin disorders
IL162485A0
(en )
2005-11-20
Compounds for the treatment of inflammatory disorders
AU2003286728A8
(en )
2004-06-07
Compounds for the treatment of metabolic disorders
AU2003256650A1
(en )
2004-02-09
Substituted thiophene carboxamide compounds for the treatment of inflammation
IL163871A0
(en )
2005-12-18
Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
HK1080859A1
(en )
2006-05-04
Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
AU2003289652A1
(en )
2004-07-09
The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
HRP20041160A2
(en )
2005-08-31
Novel combination for the treatment of airway disorders
AU2002258798A1
(en )
2002-10-28
Methods for the treatment of hepatic disorders
SI1503747T1
(en )
2006-12-31
Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
GB0201025D0
(en )
2002-03-06
The treatment of degenerative diseases
AU2003240174A8
(en )
2003-12-22
Compositions for the treatment of edematous-firbrosclerotic panniculopathy
HRP20041159A2
(en )
2005-08-31
Combination for the treatment of airway disorders
AU2003243214A1
(en )
2003-12-12
Salts of bis-arylsulfones for the treatment of cns disorders
AU2003252187A8
(en )
2003-12-02
Topical composition for the treatment of inflammatory conditions of the skin
AU2003239967A1
(en )
2003-12-22
Compound for the treatment of cns disorders
ZA200410074B
(en )
2005-09-27
Topical composition for the treatment of inflammatory conditions of the skin
SI1534391T1
(en )
2007-06-30
Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders